Fingerprint
Dive into the research topics of 'A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically